Adaptive Biotechnologies: 2026 Is The Durability Test, Not The Hype Cycle
Source: SeekingAlpha
2025-12-26 09:22:10 ET
Introduction
Adaptive Biotechnologies Corporation's ( ADPT ) stock has advanced another 15% since my rating upgrade to Hold in October. In fact, Seeking Alpha noted that Adaptive was the top-performing life sciences tools and services stock in 2025!...
Read the full article on Seeking Alpha
For further details see:
Adaptive Biotechnologies: 2026 Is The Durability Test, Not The Hype Cycle
Adaptive Biotechnologies Corporation
NASDAQ: ADPT
ADPT Trading
2.77% G/L:
$14.85 Last:
815,289 Volume:
$14.95 Open:
ADPT Latest News
February 05, 2026 04:05:00 pm
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results
January 22, 2026 04:05:00 pm
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
ADPT Stock Data
$2,393,790,148
142,894,616
2.45%
99
N/A
Biotechnology & Life Sciences
Healthcare
US
Seattle
